Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective real-world study of Jintiange capsules for osteoporosis-related chronic musculoskeletal pain
ChiCTR2100054084Phase 4Recruiting
- Sponsor
- Third Affiliated Hospital, Beijing University of Chinese Medicine
- Start
- Nov 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of jintiange in osteoporosis (2 arms), sponsored by Third Affiliated Hospital, Beijing University of Chinese Medicine. Primary endpoints: Clinical symptom score reduction rate, Pain VAS score and 6 more. Started Nov 2021; status: recruiting.
02
Drugs
jintiange
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ChiCTR2100054084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054084.